Article

High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation.

Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada Department of Surgery, University of Toronto, Toronto, Ontario, Canada Division of Genetics and Development, Toronto Western Research Institute and Krembil Neuroscience Centre, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Journal of Neurochemistry (Impact Factor: 4.24). 05/2012; DOI: 10.1111/j.1471-4159.2012.07789.x
Source: PubMed

ABSTRACT J. Neurochem. (2012) 10.1111/j.1471-4159.2012.07789.x ABSTRACT: Toll-like receptor-4 (TLR4) signaling has been implicated in microglial activation and propagation of inflammation following spinal cord injury (SCI). As such, modulating microglial activation through TLR4 represents an attractive therapeutic approach to treat SCI. High molecular weight hyaluronan (HMW-HA), a polymer with multiple therapeutic uses, has been previously shown to modulate TLR4 activation in macrophages and has shown early promise as a therapeutic agent in SCI. However, the mechanism associated with HMW-HA has not been fully elucidated or tested in microglia, a similar cell type. In the current study, we sought to determine the effects of HMW-HA on TLR4 activation in microglia and to gain insights into the mechanism of action. Rat primary microglial cultures were exposed to lipopolysaccharides (LPS) and HMW-HA, and the extent and mechanisms of inflammation were studied. HMW-HA decreased LPS mediated IL-1β, IL-6, and Tumor necrosis factor-α gene expression and IL-6 and nitric oxide production. This decrease was associated with a reduction in ERK 1/2 and p38 phosphorylation, was dependent on the continued presence of HMW-HA, and activation of Akt and A20 protein expression was reduced by HMW-HA. Together, our results show that HMW-HA can reduce LPS-mediated inflammatory signaling in microglia. We suggest that HA possibly mediates its effects by blocking the induction of inflammatory signaling through an extracellular mechanism.

0 Bookmarks
 · 
76 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The extracellular matrix polysaccharide hyaluronan (HA) exerts size-dependent effects on leukocyte behavior. Low-molecular weight HA is abundant at sites of active tissue catabolism and promotes inflammation via effects on Toll-like receptor signaling. Conversely, high-molecular weight HA is prevalent in uninjured tissues and is anti-inflammatory. We propose that the ability of high-molecular weight but not low-molecular weight HA to cross-link CD44 functions as a novel form of pattern recognition that recognizes intact tissues and communicates "tissue integrity signals" that promote resolution of local immune responses.
    Immunologic Research 03/2014; · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Throughout the body, the extracellular matrix (ECM) provides structure and organization to tissues and also helps regulate cell migration and intercellular communication. In the injured spinal cord (or brain), changes in the composition and structure of the ECM undoubtedly contribute to regeneration failure. Less appreciated is how the native and injured ECM influences intraspinal inflammation and, conversely, how neuroinflammation affects the synthesis and deposition of ECM after CNS injury. In all tissues, inflammation can be initiated and propagated by ECM disruption. Molecules of ECM newly liberated by injury or inflammation include hyaluronan fragments, tenascins, and sulfated proteoglycans. These act as “damage-associated molecular patterns” or “alarmins”, i.e., endogenous proteins that trigger and subsequently amplify inflammation. Activated inflammatory cells, in turn, further damage the ECM by releasing degradative enzymes including matrix metalloproteinases (MMPs). After spinal cord injury (SCI), destabilization or alteration of the structural and chemical compositions of the ECM affects migration, communication, and survival of all cells – neural and non-neural – that are critical for spinal cord repair. By stabilizing ECM structure or modifying their ability to trigger the degradative effects of inflammation, it may be possible to create an environment that is more conducive to tissue repair and axon plasticity after SCI.
    Experimental Neurology 08/2014; 258. · 4.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Injury to the CNS typically results in significant morbidity and endogenous repair mechanisms are limited in their ability to restore fully functional CNS tissue. Biologic scaffolds composed of individual purified components have been shown to facilitate functional tissue reconstruction following CNS injury. Extracellular matrix scaffolds derived from mammalian tissues retain a number of bioactive molecules and their ability for CNS repair has recently been recognized. In addition, novel biomaterials for dural mater repairs are of clinical interest as the dura provides barrier function and maintains homeostasis to CNS. The present article describes the application of regenerative medicine principles to the CNS tissues and dural mater repair. While many approaches have been exploring the use of cells and/or therapeutic molecules, the strategies described herein focus upon the use of extracellular matrix scaffolds derived from mammalian tissues that are free of cells and exogenous factors.
    Regenerative Medicine 05/2014; 9(3):367-83. · 3.50 Impact Factor

Preview

Download
0 Downloads